Fengbiao Guo Selected Research

Therapeutics

1/2021	Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
1/2021	Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies.
1/2019	Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fengbiao Guo Research Topics

Disease

3	Inflammation (Inflammations) 01/2021 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2020 - 12/2016
2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Dysbiosis 01/2021
1	Infections 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Kidney Diseases (Kidney Disease) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Obesity 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Adenocarcinoma 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2016

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2016
1	LipidsIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	AutoantigensIBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 01/2019